GaDia was founded in 2019 and is located in the Heart of Swiss Health Valley in the startup incubator BioArk in Monthey (Switzerland).

The project was initiated by Percevent J Ducrest (MSc), graduated from University of Applied Sciences Western Switzerland (HES-SO) and Bern University of Applied Sciences (BFH). Percevent received a grant from The Ark Foundation in 2018 to continue the assay development. He has conducted several R&D projects for external companies in the field of in vitro diagnostic tests and microbiology and is the inventor of 2 rapid diagnostic tests. In 2019, 2 C-level partners holding Bachelor and Master degrees in Finance and Management joined GaDia, bringing a wide expertise in corporate management positions in pharmaceutical and medical device businesses in Switzerland and abroad.

FungaDia - Cryptococcal Antigen Test Kit Brochure